SENP5 and cancer: Our analysis of drug sensitivity using the Genomics of Drug Sensitivity in Cancer (GDSC) (Geeleher et al., 2014) database revealed a potential correlation between SENP5 expression and sensitivity to 17-AAG, RDEA119, Trametinib, and Selumetinib, suggesting that these could be potential therapeutic agents targeting SENP5.